Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial

1. Hurvitz, S.A.
2. Martin, M.
3. Symmans, W.F.
4. Jung, K.H.
5. Huang, C.-S.
6. Thompson, A.M.
7. Harbeck, N.
8. Valero, V.
9. Stroyakovskiy, D.
10. Wildiers, H.
11. Campone, M.
12. Boileau, J.-F.
13. Beckmann, M.W.
14. Afenjar, K.
15. Fresco, R.
16. Helms, H.-J.
17. Xu, J.
18. Lin, Y.G.
19. Sparano, J.
20. Slamon, D.